92
Participants
Start Date
December 1, 2018
Primary Completion Date
January 31, 2020
Study Completion Date
April 15, 2020
Fluticasone furoate (FF)/Vilanterol (VI)
Patients with a positive exercise challenge test were allocated to a single administration of salbutamol (400 µg) and 22 to FF/VI (92/22 µg) in a double blind, double dummy method to assess the short-term effect on exercise induced complaints
Salbutamol
Patients with a positive exercise challenge test were allocated to a single administration of salbutamol (400 µg) and 22 to FF/VI (92/22 µg) in a double blind, double dummy method to assess the short-term effect on exercise induced complaints.
Rambam Medical Center, Haifa
Rambam Health Care Campus
OTHER